NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/27/2025
Back to search
Official data from USPTO
TAIJI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
08/19/2025
Trademark type
Combined
Nice classes
5
Filing date
04/11/2001
Registration date
08/03/2004
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/27/2025
Last transaction
08/19/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/18/1986
First use in commerce
05/20/2000
Drawing code
3
Owner type
03
Owner location
CHONGQING, CN
Examiner
LEIPZIG, MARC
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
TAIJI GROUP,CHONGQING FULING PHARMACEUTICAL FACTORY
TAI JI GROUP FU LING PHARMACEUTICAL FACTORY
Representatives
Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicinal preparations for human use for use in the treatment of hypertensionheadachesdermatological diseasescardiovascular diseaseslymphatic diseasespsychiatric diseasesskeletal diseasesmuscular diseasescancergastrointestinal diseasesallergiesinsomniadepressionanxietystressurological diseasesdiabetesheart diseaseshepatitisinfectious diseasesarthritisacneneurological diseaseof the nervous systemeye conditionstendonitistreatment of libido problems; pharmaceutical preparations of microorganisms for medical use in treating humans and for veterinary use in treating livestockdomesticated petsdomesticated animalsfor use in the treatment of hypertensionheadachesdermatological diseasescardiovascular diseaseslymphatic diseasespsychiatric diseasesskeletal diseasesmuscular diseasescancergastrointestinal diseasesallergiesinsomniadepressionanxietystressurological diseasesdiabetesheart diseaseshepatitisinfectious diseasesarthritisacneneurological diseases of the nervous systemeye conditionstendonitistreatment of libido problems; pharmaceutical preparations of organisms for use in the treatment of hypertensionheadachesdermatological diseasescardiovascular diseaseslymphatic diseasespsychiatric diseasesskeletal diseasesmuscular diseasescancergastrointestinal diseasesallergies insomnia depressionanxietystressurological diseasesdiabetesheart diseaseshepatitisinfectious diseasesarthritisacneneurological diseases of the nervous systemeye conditionstendonitistreatment of libido problems; drugs for medical usemedications used to treat hypertensionheadachesdermatological diseasescardiovascular diseaseslymphatic diseasespsychiatric diseasesskeletal diseasesmuscular diseasescancergastrointestinal diseasesallergiesinsomniadepressionanxietystressurological diseasesdiabetesheart diseaseshepatitisinfectious diseasesarthritisacneneurological diseases of the nervous systemeye conditionstendonitistreatment of libido problems; foods for medically restricted diets
Publications
History of USPTO decisions and trademark events.
44 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
07/27/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/27/2025
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
02/25/2025
PUM1
OFFICE ACTION ISSUED POU1
08/26/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/26/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
08/01/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/03/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/30/2013
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/30/2013
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/30/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/30/2013
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
09/27/2013
E89R
TEAS SECTION 8 & 9 RECEIVED
09/27/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/27/2013
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
10/06/2009
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
10/06/2009
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
09/30/2009
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/30/2009
ES8R
TEAS SECTION 8 RECEIVED
09/01/2009
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/15/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
08/03/2004
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/25/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/04/2004
FAXX
FAX RECEIVED
05/04/2004
CNRT
NON-FINAL ACTION MAILED
03/22/2004
DOCK
ASSIGNED TO EXAMINER
03/19/2004
CFIT
CASE FILE IN TICRS
03/18/2004
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/10/2004
PAPER RECEIVED
02/09/2004
IUAF
USE AMENDMENT FILED
02/05/2004
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
08/05/2003
PUBO
PUBLISHED FOR OPPOSITION
05/13/2003
NPUB
NOTICE OF PUBLICATION
04/23/2003
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/07/2003
CNEA
EXAMINERS AMENDMENT MAILED
02/03/2003
CNFR
FINAL REFUSAL MAILED
11/01/2002
DOCK
ASSIGNED TO EXAMINER
09/30/2002
REIN
REINSTATED
09/27/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/13/2002
PETR
PETITION TO REVIVE-RECEIVED
06/13/2002
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
06/07/2002
CNRT
NON-FINAL ACTION MAILED
08/15/2001
DOCK
ASSIGNED TO EXAMINER
07/20/2001
Continuous trademark protection
Get notified about every new filing that threatens TAIJI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.